Literature DB >> 6432541

Increased high density lipoproteins in diabetic children.

U Ewald, S Gustafson, T Tuvemo, B Vessby.   

Abstract

Serum lipoprotein lipid and apolipoprotein concentrations were determined in 27 diabetic children (5-18 years old) and 13 matched healthy controls. The serum cholesterol concentrations in the diabetics were slightly higher than in the controls (P less than 0.05) due to a significantly higher level of the high density lipoprotein cholesterol (P less than 0.01). Also the serum concentration of apolipoprotein A-I, the major protein constituent of the high density lipoprotein fraction, was higher in the diabetic children (P = 0.05). There were no significant differences between the groups with regard to the serum triglyceride concentrations or the apolipoprotein C-II and C-III concentrations. Neither the lipoprotein lipid nor the apolipoprotein levels were significantly correlated with variables related to the degree of regulation of the diabetic disease. No obvious explanation, based on the present data, can be given for the increased high density lipoprotein cholesterol concentrations in insulin-treated diabetics in comparison with the healthy children. It is possible, however, that the increased high density lipoprotein cholesterol concentration may be caused by an increased level of insulin in the circulation of insulin-treated diabetic children.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432541     DOI: 10.1007/bf00442440

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

1.  [On a rapid determination of the cholesterol bound to the serum alpha- and beta-lipoproteins].

Authors:  M BURSTEIN; J SAMAILLE
Journal:  Clin Chim Acta       Date:  1960-07       Impact factor: 3.786

2.  Apolipoprotein C-II and C-III levels in hyperlipoproteinemia.

Authors:  G Schonfeld; P K George; J Miller; P Reilly; J Witztum
Journal:  Metabolism       Date:  1979-10       Impact factor: 8.694

3.  Serum lipids and lipoproteins in insulin-treated diabetes. Demonstration of increased high density lipoprotein concentrations.

Authors:  E A Nikkilä; P Hormila
Journal:  Diabetes       Date:  1978-11       Impact factor: 9.461

4.  Metabolic control, glycosylated haemoglobin and high density lipoprotein cholesterol in diabetic children.

Authors:  L Klujber; D Molnár; M Kardos; V Jászai; G Soltész; J Mestyán
Journal:  Eur J Pediatr       Date:  1979       Impact factor: 3.183

5.  A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol.

Authors:  G R Warnick; J J Albers
Journal:  J Lipid Res       Date:  1978-01       Impact factor: 5.922

6.  Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein.

Authors:  W V Brown; M L Baginsky
Journal:  Biochem Biophys Res Commun       Date:  1972-01-31       Impact factor: 3.575

7.  A specific apoprotein activator for lipoprotein lipase.

Authors:  J C LaRosa; R I Levy; P Herbert; S E Lux; D S Fredrickson
Journal:  Biochem Biophys Res Commun       Date:  1970-10-09       Impact factor: 3.575

8.  Effects of bezafibrate on the serum lipoprotein lipid and apolipoprotein composition, lipoprotein triglyceride removal capacity and the fatty acid composition of the plasma lipid esters.

Authors:  B Vessby; H Lithell; K Hellsing; A M Ostlund-Lindqvist; I B Gustafsson; J Boberg; H Ledermann
Journal:  Atherosclerosis       Date:  1980-10       Impact factor: 5.162

9.  Studies of the proteins in human plasma very low density lipoproteins.

Authors:  W V Brown; R I Levy; D S Fredrickson
Journal:  J Biol Chem       Date:  1969-10-25       Impact factor: 5.157

10.  Serum apolipoproteins A-I, A-II and B in diabetic children and matched healthy controls.

Authors:  U Ewald; T Tuvemo; B Vessby; O Wålinder
Journal:  Acta Paediatr Scand       Date:  1982-01
View more
  3 in total

1.  The metabolic and hormonal effects of continuous subcutaneous insulin infusion therapy in diabetic children.

Authors:  G Soltész; D Molnár; T Decsi; A Hamar; L Klujber
Journal:  Diabetologia       Date:  1988-01       Impact factor: 10.122

2.  Circulating lipids and glycaemic control in insulin dependent diabetic children.

Authors:  K Azad; J M Parkin; S Court; M F Laker; K G Alberti
Journal:  Arch Dis Child       Date:  1994-08       Impact factor: 3.791

3.  Serum lipids and apolipoproteins in children with type 1 (insulin-dependent) diabetes during the first two years of the disease.

Authors:  M Kobbah; B Vessby; T Tuvemo
Journal:  Diabetologia       Date:  1988-04       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.